Looking At Apellis Pharmaceuticals's Recent Unusual Options Activity

A whale with a lot of money to spend has taken a noticeably bullish stance on Apellis Pharmaceuticals.

Looking at options history for Apellis Pharmaceuticals APLS we detected 13 strange trades.

If we consider the specifics of each trade, it is accurate to state that 76% of the investors opened trades with bullish expectations and 23% with bearish.

From the overall spotted trades, 11 are puts, for a total amount of $619,780 and 2, calls, for a total amount of $119,600.

Get Started

Earn 7.2% — No Matter What the Fed Does

Markets expect rate cuts — but your earnings don’t have to suffer. Lock in 7.2% until 2028 from ten individual bonds.

Get Started

What's The Price Target?

Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $25.0 to $90.0 for Apellis Pharmaceuticals over the last 3 months.

Volume & Open Interest Development

In terms of liquidity and interest, the mean open interest for Apellis Pharmaceuticals options trades today is 5493.5 with a total volume of 13,105.00.

In the following chart, we are able to follow the development of volume and open interest of call and put options for Apellis Pharmaceuticals's big money trades within a strike price range of $25.0 to $90.0 over the last 30 days.

Apellis Pharmaceuticals Option Volume And Open Interest Over Last 30 Days

Biggest Options Spotted:

Where Is Apellis Pharmaceuticals Standing Right Now?

• With a volume of 1,389,033, the price of APLS is up 20.52% at $52.12.
• RSI indicators hint that the underlying stock is currently neutral between overbought and oversold.
• Next earnings are expected to be released in 101 days.

What The Experts Say On Apellis Pharmaceuticals:

• JP Morgan has decided to maintain their Overweight rating on Apellis Pharmaceuticals, which currently sits at a price target of $79.
• Credit Suisse has decided to maintain their Neutral rating on Apellis Pharmaceuticals, which currently sits at a price target of $43.
• Jefferies downgraded its action to Hold with a price target of $40

Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.

If you want to stay updated on the latest options trades for Apellis Pharmaceuticals, Benzinga Pro gives you real-time options trades alerts.